Perrigo | PRGO - Sales Revenues


Perrigo reported $1.02B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
AbbVie USD 16.99B 1.99B Jun/2026
Abbott USD 12.59B 1.43B Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Corcept Therapeutics USD 256.15M 91.25M Jun/2026
Dr.Reddys Laboratories INR 80.71B 5.25B Jun/2026
Eli Lilly USD 22.97B 3.17B Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Merck USD 16.6B 310M Jun/2026
Nestle CHF 43.11B 2.15B Jun/2026
Pacira USD 192.4M 15.4M Jun/2026
Perrigo USD 1.02B 51M Jun/2026
Pfizer USD 15.03B 530M Jun/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 265.71M 15.91M Jun/2026
Reckitt Benckiser GBP 7.26B 3.96B Dec/2025
Sanofi EUR 11.95B 710M Jun/2026
Supernus Pharmaceuticals USD 219.1M 11.39M Jun/2026
Teva Pharmaceutical Industries USD 12.67B 900M Jun/2026
Xeris Pharmaceuticals USD 83.13M 2.68M Mar/2026
Zoetis USD 2.5B 200M Jun/2026